Information
A 5-day-old male infant was admitted to hospital with a history of poor feeding and fever. He was born at term to a 22-year-old woman (gravida 1, para 0). The delivery took place at home and was uncomplicated. The birth weight was 3300 g.
On admission, a child with mild respiratory distress and tachypnoea was seen. The rectal temperature was 37.5 ~ C. There was an oxygen demand of 25%. Laboratory tests included haemoglobin 12.5 mmol/1, haematocrit 0.60 1/1, platelet count 306 x 109/1, WBC count 10.9 x 109/1 with 8% band forms, 33% neutrophils and 58% lymphocytes, serum CRP level 56 rag/1 and capillary blood gas analysis pH 7.28, PCO2 9 kPa, bicarbonate 32.1 mmol/l, base-excess +3.3 retool/1. A chest radiograph showed a lobar infiltrate in the right upper lobe. Bacteriological cultures of blood, sputum and CSF remained negative. The infant was treated with intravenous ampicillin and cefotaxim. When his clinical condition did not improve intravenous erythromycin was added. A new chest radiograph at day 11 showed complete consolidation of the right lung (Fig. 1) .
The child was subsequently transferred to our hospital. On admission a moderately ill child was seen with tachypnoea (respiratory rate: 60/min) and oxygen demand (46%). The rectal temperature was 36.7 ~ C. Auscultation of the right lung revealed decreased breathsounds and rhonchi. Laboratory results included haematocrit 0.52 1/1, platelet count 79 x 109/1, WBC count 14.6 x 109/1 and CRP level 56 rag/1. Capillary blood gas analysis revealed pH 7.39, PCO2 7.3 kPa, base-excess +7 mmol/1. CSF analysis showed 12 cells/3 mm 3, glucose and protein levels 2.5 mmol/1 and 84 mg/100 ml respectively. A bronchoscopy with broncho-alveolar lavage was performed on day 11. Purulent secretion was seen in the right upper lobe.
Treatment was started with amoxicillin/clavulanic acid (25/2.5 mg/kg qid), tobramycin (3 mg/kg once daily) and erythromycin (5 mg/kg qid) intravenously. At the age of 14 days the patient developed an erythematous rash, which disappeared spontaneously after 1 day. Bacterial cultures remained negative. On day 19 results of viral cultures were obtained. 
Discussion
Neonatal HSV infection is a rare but serious infection with a high morbidity and mortality. The incidence has been estimated at 200-500 per 100000 live births in the USA and at 2 per 100 000 in the United Kingdom [11] . In approximately 80% of neonatal HSV infections, the virus is transmitted during labour. Infection is due to transplacental spread in 5% and is postnatally acquired in 15% [16] .
Neonatal HSV infection may produce a variety of patterns of clinical disease. Localised infection of eye, mouth and throat is seen in 43%, meningo-encephalitis is 34% and disseminated infection in 23% [17] . The mortality rate in these groups is 0%, 15% and 57% respectively [18] .
The isolated occurrence of HSV pneumonia has occasionally been reported [1, 3-5, 7, 9, 10, 13, 14] . In most cases it is part of a disseminated syndrome with multi-organ failure and intravascular coagulation. Approximately 20% of infants with disseminated HSV infection have radiological evidence of pneumonitis or pleural effusion [7] . To date only 15 patients with primary HSV pneumonia with or without disseminated infection have been reported [1, 3-5, 7, 9, 10, 13, 14] . All patients presented with respiratory distress and abnormal chest radiographs within the first 10 days of life. In 8 of these newborns the correct diagnosis was suspected and therapy was started before or on the 5th day after onset of symptoms. Five of the patients survived. All other neonates with the exception of the one described above, died.
Clinically the diagnosis of HSV type 2 pneumonia is difficult. In only 1 of the 15 children could a history of prior HSV infection in the mother be obtained [14] . Only 3 of 14 previously described neonates had a vesicular rash [5, 7, 10] . Our patient had a erythematous rash on day 14 of life, which disappeared within 24 h. The fact, that the virus culture was positive for HSV 2 after 7 days indicates the presence of a low virus load, since HSV usually demonstrates cytopathic changes after I-2 days. Furthermore it is conceivable, that some neutralization took place.
Hubbell et al. [7] have suggested to start antiviral treatment when the aetiology of the pneumonia is unknown and one of the following parameters is present: thrombocytopenia, evidence of disseminated intravascular coagulation, elevated liver function tests, a positive result in a rapid screening test for HSV, lymphocytic pleiocytosis of the CSF, development of vesicular skin lesions or further deterioration in clinical status during treatment with antibiotics. Our patient illustrates the usefulness of this advice. The progression of the pneumonia despite antibiotic treatment and a prior vesicular rash should have led to an earlier start of therapy with acyclovir.
Approximately 50% of infants from mothers with primary genital infection by HSV become infected, whereas less than 5% of infants exposed to recurrent maternal infection at the time of delivery are infected [2] . This is mainly due to the fact that in recurrent HSV infections the cervix is less frequently infected. Furthermore, HSV is present in the genital tract in lower titres and for a shorter time during a recurrent infection than during a primary infection [ 12] . The role of neutralizing antibodies in influencing the attack rate and clinical manifestations remains controversial [2, 8, 12, 15] . In a study of 55 patients by Prober et al. [12] absence of neutralizing antibodies to HSV was associated with the onset of symptoms of HSV infection during the 1st week of life and with disseminated infection. Infants with neutralizing antibodies to HSV tended to have localised infections at an older age. However Kahlon and Whitley [8] could not confirm a significant correlation between antibody status and clinical outcome.
We suggest that a low virus load in combination with transplacental passage of neutralizing antibodies has ,~iil ~ ~ii~i , ~,~ ,,,~3~, ~ i resulted in a mild infection in our patient, allowing complete recovery despite a substantial delay in treatment.
